Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Menten

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
European Journal of Cancer (Oxford, England : 1990)|October 24, 2008
MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastomaJ Sadones, A Michotte, P Veld, et al.
Neurology|September 15, 2004
Salvage PCV chemotherapy for temozolomide-resistant oligodendrogliomasV H J M Triebels, M J B Taphoorn, A A Brandes, et al.
Journal of Cancer Research and Clinical Oncology|January 20, 2021
Features of durable response and treatment efficacy for capecitabine monotherapy in advanced breast cancer: real-world evidence from a large single-centre cohortS Thijssen, H Wildiers, K Punie, et al.
Investigative Ophthalmology & Visual Science|February 4, 2025
Targeted Microperimetry Grids for Focal Lesions in Intermediate AMD: PINNACLE Study Report 7Stefan Futterknecht, Philipp Anders, Julia Mai, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 2011
Stellate ganglion block for the management of hot flashes and sleep disturbances in breast cancer survivors: an uncontrolled experimental study with 24 weeks of follow-upK Haest, A Kumar, B Van Calster, et al.
Eye (London, England)|May 25, 2022
Developing and validating a multivariable prediction model which predicts progression of intermediate to late age-related macular degeneration-the PINNACLE trial protocolJanice Sutton, Martin J Menten, Sophie Riedl, et al.
NPJ Digital Medicine|August 19, 2025
Specialized curricula for training vision language models in retinal image analysisRobbie Holland, Thomas R P Taylor, Christopher Holmes, et al.
Ophthalmology Science|April 28, 2023
Exploring Healthy Retinal Aging with Deep LearningMartin J Menten, Robbie Holland, Oliver Leingang, et al.
Neuro-Oncology Advances|November 12, 2021
Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG03.01) randomized clinical trialAndrew J Song, Keyue Ding, Iyad Alnahhas, et al.
Neuro-Oncology Advances|January 31, 2022
Corrigendum to: Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG 08.02) randomized clinical trialAndrew J Song, Keyue Ding, Iyad Alnahhas, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
European Journal of Cancer (Oxford, England : 1990)|October 24, 2008
MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastomaJ Sadones, A Michotte, P Veld, et al.
Neurology|September 15, 2004
Salvage PCV chemotherapy for temozolomide-resistant oligodendrogliomasV H J M Triebels, M J B Taphoorn, A A Brandes, et al.
Journal of Cancer Research and Clinical Oncology|January 20, 2021
Features of durable response and treatment efficacy for capecitabine monotherapy in advanced breast cancer: real-world evidence from a large single-centre cohortS Thijssen, H Wildiers, K Punie, et al.
Investigative Ophthalmology & Visual Science|February 4, 2025
Targeted Microperimetry Grids for Focal Lesions in Intermediate AMD: PINNACLE Study Report 7Stefan Futterknecht, Philipp Anders, Julia Mai, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 2011
Stellate ganglion block for the management of hot flashes and sleep disturbances in breast cancer survivors: an uncontrolled experimental study with 24 weeks of follow-upK Haest, A Kumar, B Van Calster, et al.
Eye (London, England)|May 25, 2022
Developing and validating a multivariable prediction model which predicts progression of intermediate to late age-related macular degeneration-the PINNACLE trial protocolJanice Sutton, Martin J Menten, Sophie Riedl, et al.
NPJ Digital Medicine|August 19, 2025
Specialized curricula for training vision language models in retinal image analysisRobbie Holland, Thomas R P Taylor, Christopher Holmes, et al.
Ophthalmology Science|April 28, 2023
Exploring Healthy Retinal Aging with Deep LearningMartin J Menten, Robbie Holland, Oliver Leingang, et al.
Neuro-Oncology Advances|November 12, 2021
Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG03.01) randomized clinical trialAndrew J Song, Keyue Ding, Iyad Alnahhas, et al.
Neuro-Oncology Advances|January 31, 2022
Corrigendum to: Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG 08.02) randomized clinical trialAndrew J Song, Keyue Ding, Iyad Alnahhas, et al.
Pageof 8